Symbiotec Pharmalab Limited experienced significant insider trading activity on September 30, 2026. Fourteen designated persons executed sixteen sell transactions, totaling 118.8 million INR in divestments. These sales involved 95,670 shares, reflecting a broad pattern of liquidation among key personnel without any corresponding buy orders recorded during this period.